A Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder.
Phase of Trial: Phase II/III
Latest Information Update: 10 Oct 2014
At a glance
- Drugs Edivoxetine (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 24 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 May 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.